TTY Biopharm Co (ROCO:4105) Scaled Net Operating Assets : 0.63 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TTY Biopharm Co's operating assets for the quarter that ended in Sep. 2024 was NT$7,762 Mil. TTY Biopharm Co's operating liabilities for the quarter that ended in Sep. 2024 was NT$1,301 Mil. TTY Biopharm Co's Total Assets for the quarter that ended in Jun. 2024 was NT$10,250 Mil. Therefore, TTY Biopharm Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.63.

TTY Biopharm Co Scaled Net Operating Assets Historical Data

The historical data trend for TTY Biopharm Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co Scaled Net Operating Assets Chart

TTY Biopharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.54

0.59

0.57

0.58

TTY Biopharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.62	0.56	0.48	0.60	0.63

Competitive Comparison of TTY Biopharm Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TTY Biopharm Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Scaled Net Operating Assets falls into.

TTY Biopharm Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TTY Biopharm Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(7058.352	-	1453.723)	/	9600.635
=	0.58

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	9874.909	-	2816.557
=	7058.352

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3368.767	-	403.047	-	1511.997
=	1453.723

TTY Biopharm Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(7761.727	-	1301.072)	/	10249.88
=	0.63

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10644.722	-	2882.995
=	7761.727

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3674.419	-	5.351	-	2367.996
=	1301.072

TTY Biopharm Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

TTY Biopharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503

Website

https://www.tty.com.tw

TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co Headlines

No Headlines